StockData

NuCana plc (NCNA) stock

NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 1/30
$0.86−0.07 (-7.53%)

Close on Nov 16, 2026Market cap $3.58MP/E –Yield –

NuCana price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for NuCana

NuCana has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NuCana figures

See a number that looks wrong?